http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111588706-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
filingDate 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111588706-B
titleOfInvention Mercaptopurine nanoparticles and preparation method thereof
abstract The invention discloses mercaptopurine nanoparticles and a preparation method thereof. Including: (1) dissolving PLGA in an organic solvent to form a PLGA oil phase O; (2) dissolving the solid mercaptopurine in an inner aqueous phase containing a stabilizer to form an aqueous mercaptopurine solution W1; (3) adding it to the PLGA oil Form W1/O colostrum emulsion in phase O; (4) inject W1/O colostrum emulsion into outer water phase W2 to obtain W1/O/W2 double emulsion emulsion; (5) remove organic solvent and solidify to form nanoparticles; (6) After washing and dispersing, add a freeze-drying protective agent to freeze-dry, and obtain. The invention uses PLGA as a carrier to prepare mercaptopurine nanoparticles, can control the release of drugs according to the molecular weight of PLGA and the ratio of polymers, can effectively improve the bioavailability of drugs with poor water solubility, the preparation method is simple, and the prepared nanoparticles have uniform particle size, The encapsulation efficiency is good, the drug loading capacity is high, the oral administration is convenient, and the nanoparticles after lyophilization are convenient for children to divide the dose.
priorityDate 2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408857276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 32.